Cargando…

Near-complete response to low-dose ceritinib in recurrent infantile inflammatory myofibroblastic tumour

Mostrar otras versiones (1)

BACKGROUND: Infantile inflammatory myofibroblastic tumour (IMT) is rare and the majority are driven by anaplastic lymphoma kinase (ALK) rearrangements. Previous literature on the use of ALK inhibitors in paediatric IMTs is extremely limited with no published literature on the use in infants. Crizoti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mittal, Abhenil, Gupta, Aarushi, Rastogi, Sameer, Barwad, Adarsh, Sharma, Swati
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057779/ https://www.ncbi.nlm.nih.gov/pubmed/33912240 http://dx.doi.org/10.3332/ecancer.2021.1215

Ejemplares similares

Near-complete response to low-dose ceritinib in recurrent infantile inflammatory myofibroblastic tumour
por: Mittal, Abhenil, et al.
Publicado: (2021)

Recurrent infantile inflammatory myofibroblastic tumor of mesentery––Case report and review of imaging findings
por: Gupta, Aarushi, et al.
Publicado: (2020)

Imaging and Pathological Features of Alveolar Soft Part Sarcoma: Analysis of 16 Patients
por: Gulati, Malvika, et al.
Publicado: (2021)

Limb salvage of an infant with infantile fibrosarcoma using TRK inhibitor larotrectinib
por: Sahni, Shubham, et al.
Publicado: (2023)

Recurrent Aggressive Fibromatosis Coexisting With Papillary Carcinoma Thyroid – Case Report
por: BG, Bharath, et al.
Publicado: (2023)

A rare case of clear cell sarcoma of the foot with a cascade of pathological misdiagnosis—the importance of expert sarcoma pathology
por: Rajendran, Anand, et al.
Publicado: (2022)

Insights into the medical management of gastrointestinal stromal tumours: lessons learnt from a dedicated gastrointestinal stromal tumour clinic in North India
por: Baa, Annie Kanchan, et al.
Publicado: (2023)

Long lasting response with trabectedin monotherapy in relapsed metastatic mesenchymal chondrosarcoma
por: Tansir, Ghazal, et al.
Publicado: (2020)

Early clinical and metabolic response to tazemetostat in advanced relapsed INI1 negative epithelioid sarcoma
por: Tansir, Ghazal, et al.
Publicado: (2021)

Challenges in the management of metastatic gastrointestinal stromal tumor in a patient with neurofibromatosis type 1: a case report
por: Bharath, B. G., et al.
Publicado: (2022)

Tracheal glomus tumor: An aggressive rare neoplasm
por: Kumar, Navin, et al.
Publicado: (2020)

A case report of Kaposiform haemangioendothelioma; response with propranolol and steroids
por: Verma, Saurav, et al.
Publicado: (2020)

Good and sustained response to pembrolizumab and pazopanib in advanced undifferentiated pleomorphic sarcoma: a case report
por: Arora, Shalabh, et al.
Publicado: (2020)

Metastatic sclerosing epithelioid fibrosarcoma in an adult male from a tertiary care centre in India: a case report
por: Santhosh, Akhil, et al.
Publicado: (2022)

Chromoplectic TPM3–ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib
por: Mansfield, A. S., et al.
Publicado: (2016)

Advanced Dermatofibrosarcoma Protuberans Treatment With Imatinib: Experience From a Dedicated Sarcoma Medical Oncology Clinic in India
por: Rastogi, Sameer, et al.
Publicado: (2018)

An Unusual Case of Synovial Sarcoma with Breast Metastasis: Findings on Positron Emission Tomography-Computed Tomography
por: Upadhyay, Avinash, et al.
Publicado: (2020)

Radio-pathological and Clinical Correlation of Aggressive Angiomyxoma: Experience of a Tertiary Care Cancer Hospital
por: Dhamija, Ekta, et al.
Publicado: (2021)

A Phase 0 Trial of Ceritinib in Patients with Brain Metastases and Recurrent Glioblastoma
por: Mehta, Shwetal, et al.
Publicado: (2022)

Partial response to erlotinib in a patient with imatinib-refractory sacral chordoma
por: Verma, Saurav, et al.
Publicado: (2020)

Intra-abdominal infantile inflammatory myofibroblastic tumors: A report of three cases
por: Banerjee, Mala, et al.
Publicado: (2014)

Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma
por: Beck, Olaf, et al.
Publicado: (2020)

Two Cases of Infantile Intra-abdominal Inflammatory Myofibroblastic Tumor
por: Kim, Soo-Hong, et al.
Publicado: (2014)

Inflammatory myofibroblastic tumour of the gallbladder
por: Behranwala, Kasim A, et al.
Publicado: (2005)

Recurrent periorbital low-grade myofibroblastic sarcoma in an infant
por: Modaboyina, Sujeeth, et al.
Publicado: (2022)

Lessons learnt from the clinico-genomic profiling of families with Li Fraumeni syndrome at a tertiary care centre in North India
por: Tansir, Ghazal, et al.
Publicado: (2023)

Acute Interstitial Lung Disease Induced by Rechallenge with Ceritinib
por: Hotta, Takamasa, et al.
Publicado: (2019)

Trabectedin in Advanced Sarcomas—Experience at a Tertiary Care Center and Review of Literature
por: Verma, Saurav, et al.
Publicado: (2021)

Inflammatory Myofibroblastic Tumour of the Skull Base
por: Maire, Jean-Philippe, et al.
Publicado: (2013)

Inflammatory Myofibroblastic Tumour: State of the Art
por: Gros, Louis, et al.
Publicado: (2022)

Successful rechallenge with ceritinib after leukocytoclastic vasculitis during ceritinib treatment for non-small cell lung cancer harboring the EML4-ALK fusion protein
por: Okimoto, Tamio, et al.
Publicado: (2018)

Advanced dermatofibrosarcoma protuberans: an updated analysis of cases from an Indian sarcoma clinic
por: Rasheed, Azgar A, et al.
Publicado: (2021)

Clinicopathological profile and outcomes of anorectal melanoma from a tertiary care center in India
por: Garg, Vikas, et al.
Publicado: (2022)

Management and outcomes of advanced hemangioendothelioma at a medical oncology clinic in an Indian tertiary care center
por: Tansir, Ghazal, et al.
Publicado: (2023)

Inflammatory myofibroblastic tumours: a pictorial review
por: Cantera, Jon Etxano, et al.
Publicado: (2014)

Multimodality treatment of head-and-neck soft-tissue sarcomas and short-term outcomes: Analysis from sarcoma medical oncology clinic
por: Vanidassane, Ilavarasi, et al.
Publicado: (2019)

A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma
por: Tansir, Ghazal, et al.
Publicado: (2023)

Ceritinib for ALK-Rearrangement–Positive Non–Small Cell Lung Cancer
por: Nix, Nancy M., et al.
Publicado: (2015)

Spotlight on ceritinib in the treatment of ALK+ NSCLC: design, development and place in therapy
por: Santarpia, Mariacarmela, et al.
Publicado: (2017)

Ceritinib‐associated hyperglycemia in the Japanese Adverse Drug Event Report Database
por: Fujita, Haruka, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_654ie4mpsm4fnp8c1rno4nb5s1